563. Deputy Bobby Aylward asked the Minister for Health when the final report on valproate will be published; the reason for the delay in finalising same to date; and if he will make a statement on the matter. [44692/19]

564. Deputy Bobby Aylward asked the Minister for Health if he will meet representative bodies to discuss progress on recommendations in a report (details supplied); and if he will make a statement on the matter. [44693/19]

565. Deputy Bobby Aylward asked the Minister for Health the position regarding the apparent lack of availability of official documentation regarding the licensing of a drug (details supplied) within the public sphere; his views on the need for total transparency in respect of same and the need for a possible investigation in respect of same; and if he will make a statement on the matter. [44694/19]

I propose to take Questions Nos. 563 to 565, inclusive, together.

I am due to receive a briefing on the HSE's Valproate Response Project report shortly. No decision has been taken regarding potential publication of the report.

I am advised that some documentation regarding the licensing of Epilim has previously been shared with the representative body referred to by the Deputy. I will ask Department and Health Products Regulatory Authority (HPRA) officials to consider whether additional documents could be released. I am also happy to consider a meeting with the representative bodies referred to by the Deputy if a request is submitted to my office in the Department.